Viatris – Global Leader in Quality Pharmaceutical Solutions

Viatris

Viatris is a global American pharmaceutical corporation formed in 2020 through the merger of healthcare giants Mylan and Upjohn (a former division of Pfizer). The company combines scientific expertise and world-class manufacturing capabilities, offering a vast portfolio of branded medicines and high-quality generics. The manufacturer's operations span key therapeutic areas, including oncology, cardiology, immunology, and dermatology. Viatris products meet strict FDA and EMA standards, ensuring patient access to effective treatments worldwide.